Ultragenyx Reports Second Quarter 2021 Financial Results and Corporate Update
Go back to Ultragenyx Reports Second Quarter 2021 Financial Results and Corporate Update| ULTRAGENYX PHARM (NASDAQ: RARE) | Delayed: 14.31 -0.57 (3.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.88 | 52 Week High | $117.12 | |||
| Open | $14.77 | 52 Week Low | $46.52 | |||
| Day High | $15.19 | P/E | N/A | |||
| Day Low | $14.27 | EPS | $-1.97 | |||
| Volume | 4,563,180 | |||||
